# Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME

> A sourced UK public-sector contract award published by Manchester University NHS Foundation Trust.

## Key facts

- Public buyer: [Manchester University NHS Foundation Trust](/buyers/manchester-university-nhs-foundation-trust/contract-awards)
- Contract winner: Clinical Architecture Limited
- Award value: £268,488
- Tender value: £268,488
- Award date: 23 October 2024
- Published: 24 December 2024
- Contract start: 17 December 2024
- Contract end: 31 March 2026
- Stage: awarded
- Procurement category: goods
- Notice ID: b7874f4a-dd8a-45f6-9619-1fc554e1e917-813757
- OCID: ocds-b5fd17-8641e8f8-34ab-488a-a7f3-dab128f7737f

## Description

The "Pharmacogenetics as a Service" component of the PROGRESS Programme aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data\. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS\.

## Related contract awards

- [LAMP testing \(Loop-mediated isothermal amplification\)](/contracts/ocds-b5fd17-1b605a22-ce5d-447c-8835-9cdb91a323a4): Manchester University NHS Foundation Trust
- [Provision of Diagnostic Scans for Cardiac](/contracts/ocds-b5fd17-2092d808-1192-4a79-9296-bec946274a5b): Manchester University NHS Foundation Trust
- [Vascular Scanning Service](/contracts/ocds-b5fd17-1b88d3e0-e0a8-45c0-904c-aa01b110d0aa): Manchester University NHS Foundation Trust

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/b7874f4a-dd8a-45f6-9619-1fc554e1e917-813757)